October 2022 - Mapp Biopharmaceutical, Inc.

BARDA collaborates with Mapp Biopharmaceutical, Inc. to advance the development of a therapeutic for Marburg virus disease

by Mapp Admin | Oct 27, 2022 | Press Releases

BARDA collaborates with Mapp Biopharmaceutical, Inc. to advance the development of a therapeutic for Marburg virus disease To further enhance preparedness against health security threats, BARDA is extending a partnership with Mapp...

ASPR awards $110 million to advance development, procure therapeutic for Sudan ebolavirus

by Mapp Admin | Oct 4, 2022 | Press Releases

ASPR awards $110 million to advance development, procure therapeutic for Sudan ebolavirus The Administration for Strategic Preparedness and Response (ASPR) today announced a $109.8 million contract with Mapp Biopharmaceutical Inc., for the advanced...

July 2024
May 2024
October 2022
January 2021
June 2019
January 2019
September 2018

BARDA collaborates with Mapp Biopharmaceutical, Inc. to advance the development of a therapeutic for Marburg virus disease

ASPR awards $110 million to advance development, procure therapeutic for Sudan ebolavirus

Archives

Categories

New human trials for novel antibody offer hope for immediate protection against deadly Nipah

BARDA collaborates with Mapp Biopharmaceutical, Inc. to advance the development of a therapeutic for Marburg virus disease